GE Healthcare, Roche ally in Alzheimer's disease

01 Sep 2005

GE Healthcare and Roche have signed an agreement for the development of personalized therapies for Alzheimer's disease (AD) patients.

In Vitro Diagnostics
Pharmaceuticals
Medical Devices
- Diagnostic Imaging Equipment & Supplies
Biotechnology
- Pharmacogenetics-Pharmacogenomics
- Drug Discovery Tools
  - Genomics-Proteomics

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

GE Healthcare, Roche ally in Alzheimer's disease

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice